After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Buy an 8GB RAM smartphone for office work, more storage, and fast charging
Nowadays people do their office work the most on laptops and phones. Through phone calls, WhatsAp
There has been a major reshuffle at the management level in Mukesh Ambani's company Reliance Jio
Great discomfort in Bangladesh and Brazil for vaccine made in India
After the approval of the emergency use of two vaccines for the Coronavirus in India, countries l
UP Election 2022: Understand BJP's Chanakya Amit Shah's UP plan
UP Election 2022: By the end of this month, Amit Shah will come in the role of Chanakya for BJP i
Big news has come from the giant tech company Infosys. The salary of the company's CEO Salil Pare
Janhvi remembered Sridevi while giving a house tour: Said- Mother never allowed to lock the bathroom
Janhvi Kapoor recently gave fans a house tour of her Chennai home. During this, he shared all the
Prime Minister Modi, citing his visit to South India during the fast observed before the consecra
Pak intruder gunned down in Arnia sector adjacent to India-Pakistan international border
Border Security Force personnel have killed a Pakistani infiltrator trying to infiltrate into the
Raksha Bandhan Aarti Thali: The festival of Rakshabandhan is celebrated every year on the full mo
Microsoft claimed in a report on Wednesday that Russia has intensified hacking attempts against U
